| Fund ID | 805-5893926980 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 91% |
| Fund | Type | Gross assets |
|---|---|---|
| Innovatus Life Sciences Lending Fund I, LP | Private Equity | $368.7M |
| Innovatus Flagship Fund I, LP | Private Equity | $116.9M |
| Innovatus Emirates Offshore Fund I, LP | Private Equity | $111.9M |
Innovatus Life Sciences Offshore Fund I-A, LP reports $205.4 million in gross assets, among the top 30% of private funds by size.
The stated minimum investment is $2 million.
Innovatus Life Sciences Offshore Fund I-A, LP is managed by Innovatus Capital Partners, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.